As 80% of bladder tumors harbor HRAS mutations [10] and more than half of bladder tumors overexpress HRAS[11], both mutation and overexpression are important factors in the tumorigenesis of bladder cancer [12]. Here, HRAS is linked to urinary bladder cancer.